Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Smits

Showing results (131-140 of 220) with videos related to

Pageof 22
Sort By:
Neuro-Oncology Practice|March 20, 2025
Perfusion MRI-based differentiation between early tumor progression and pseudoprogression in glioblastoma and its use in clinical practiceDaniëlle van Dorth, Robert J I Croese, Feng Yan Jiang, et al.
Neuroimage. Clinical|November 2, 2013
The influence of cerebral small vessel disease on default mode network deactivation in mild cognitive impairmentJanne M Papma, Tom den Heijer, Inge de Koning, et al.
European Radiology|January 28, 2024
Differentiating IDH-mutant astrocytomas and 1p19q-codeleted oligodendrogliomas using DSC-PWI: high performance through cerebral blood volume and percentage of signal recovery percentilesAlbert Pons-Escoda, Alonso Garcia-Ruiz, Pablo Naval-Baudin, et al.
Neuroimage. Clinical|May 26, 2016
Structural and functional brain abnormalities place phenocopy frontotemporal dementia (FTD) in the FTD spectrumRebecca M E Steketee, Rozanna Meijboom, Esther E Bron, et al.
Journal of Medical and Biological Engineering|December 9, 2020
GliMR: Cross-Border Collaborations to Promote Advanced MRI Biomarkers for GliomaPatricia Clement, Thomas Booth, Fran Borovečki, et al.
Frontiers in Oncology|June 2, 2020
Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter MethylationFatih Incekara, Sebastian R van der Voort, Hendrikus J Dubbink, et al.
Human Brain Mapping|October 12, 2013
Cerebral small vessel disease affects white matter microstructure in mild cognitive impairmentJanne M Papma, Marius de Groot, Inge de Koning, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 11, 2017
Variability of physiological brain perfusion in healthy subjects - A systematic review of modifiers. Considerations for multi-center ASL studiesPatricia Clement, Henk-Jan Mutsaerts, Lena Václavů, et al.
Neuro-Oncology Advances|April 14, 2022
The impact of different volumetric thresholds to determine progressive disease in patients with recurrent glioblastoma treated with bevacizumabRenske Gahrmann, Marion Smits, René Michel Vernhout, et al.
Neuro-Oncology|February 17, 2017
Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab-a report from the BELOB trialRenske Gahrmann, Martin van den Bent, Bronno van der Holt, et al.
Pageof 22

Showing results (131-140 of 220) with videos related to

Sort By:
Pageof 22
Neuro-Oncology Practice|March 20, 2025
Perfusion MRI-based differentiation between early tumor progression and pseudoprogression in glioblastoma and its use in clinical practiceDaniëlle van Dorth, Robert J I Croese, Feng Yan Jiang, et al.
Neuroimage. Clinical|November 2, 2013
The influence of cerebral small vessel disease on default mode network deactivation in mild cognitive impairmentJanne M Papma, Tom den Heijer, Inge de Koning, et al.
European Radiology|January 28, 2024
Differentiating IDH-mutant astrocytomas and 1p19q-codeleted oligodendrogliomas using DSC-PWI: high performance through cerebral blood volume and percentage of signal recovery percentilesAlbert Pons-Escoda, Alonso Garcia-Ruiz, Pablo Naval-Baudin, et al.
Neuroimage. Clinical|May 26, 2016
Structural and functional brain abnormalities place phenocopy frontotemporal dementia (FTD) in the FTD spectrumRebecca M E Steketee, Rozanna Meijboom, Esther E Bron, et al.
Journal of Medical and Biological Engineering|December 9, 2020
GliMR: Cross-Border Collaborations to Promote Advanced MRI Biomarkers for GliomaPatricia Clement, Thomas Booth, Fran Borovečki, et al.
Frontiers in Oncology|June 2, 2020
Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter MethylationFatih Incekara, Sebastian R van der Voort, Hendrikus J Dubbink, et al.
Human Brain Mapping|October 12, 2013
Cerebral small vessel disease affects white matter microstructure in mild cognitive impairmentJanne M Papma, Marius de Groot, Inge de Koning, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 11, 2017
Variability of physiological brain perfusion in healthy subjects - A systematic review of modifiers. Considerations for multi-center ASL studiesPatricia Clement, Henk-Jan Mutsaerts, Lena Václavů, et al.
Neuro-Oncology Advances|April 14, 2022
The impact of different volumetric thresholds to determine progressive disease in patients with recurrent glioblastoma treated with bevacizumabRenske Gahrmann, Marion Smits, René Michel Vernhout, et al.
Neuro-Oncology|February 17, 2017
Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab-a report from the BELOB trialRenske Gahrmann, Martin van den Bent, Bronno van der Holt, et al.
Pageof 22